GlyCosmos Glycoproteins

Integrated list of glycoproteins extracted from UniProt and annotated with glycosylation data from GlyGen and GlyConnect. For each entry, information such as glycosylation site, glycans, diseases, 3D structures, and pathway information are available.

Database Last Updated
GlyConnect April 19, 2023
GlycoProtDB October 1, 2021
GlyGen October 2, 2023
Human Protein Atlas June 19, 2023 (Protein Atlas version 23)
MCAW-DB July 10, 2019
The O-GlcNAc Database April 10, 2023 (v1.3)
Reactome February 28, 2024 (Version 87)
UniProt December 27, 2023
Protein Name UniProt ID Gene Symbol Species Taxonomy ID No. of Glycosylation Sites ▼ GO Labels GO IDs
  • BN1205_062230
432359
  • Golgi membrane
  • histone acetyltransferase activity
  • intracellular protein transport
  • membrane coat
  • structural molecule activity
  • vesicle-mediated transport
  • GO:0000139
  • GO:0004402
  • GO:0005198
  • GO:0006886
  • GO:0016192
  • GO:0030117
  • Tc00.1047053507541.40
353153
  • ATP binding
  • phosphorylation
  • protein serine/threonine kinase activity
  • GO:0004674
  • GO:0005524
  • GO:0016310
  • Lss
10090
  • cholesterol biosynthetic process
  • endoplasmic reticulum membrane
  • lanosterol synthase activity
  • lipid droplet
  • regulation of protein stability
  • steroid biosynthetic process
  • sterol metabolic process
  • triterpenoid biosynthetic process
  • GO:0000250
  • GO:0005789
  • GO:0005811
  • GO:0006694
  • GO:0006695
  • GO:0016104
  • GO:0016125
  • GO:0031647
  • Tc00.1047053507053.90
353153
  • Tc00.1047053511523.14
353153
  • membrane
  • GO:0016020
  • Sars1
10090
  • ATP binding
  • RNA polymerase II cis-regulatory region sequence-specific DNA binding
  • cytoplasmic translation
  • cytosol
  • enzyme binding
  • molecular adaptor activity
  • negative regulation of angiogenesis
  • negative regulation of transcription by RNA polymerase II
  • negative regulation of vascular endothelial growth factor production
  • nucleus
  • protein homodimerization activity
  • selenocysteine incorporation
  • selenocysteine-tRNA ligase activity
  • serine-tRNA ligase activity
  • seryl-tRNA aminoacylation
  • tRNA modification
  • GO:0000122
  • GO:0000978
  • GO:0001514
  • GO:0002181
  • GO:0004828
  • GO:0005524
  • GO:0005634
  • GO:0005829
  • GO:0006400
  • GO:0006434
  • GO:0016525
  • GO:0019899
  • GO:0042803
  • GO:0060090
  • GO:0098619
  • GO:1904046
  • Ncoa1
10116
  • DNA binding
  • RNA polymerase II transcription regulator complex
  • RNA polymerase II transcription regulatory region sequence-specific DNA binding
  • cellular response to Thyroglobulin triiodothyronine
  • cellular response to hormone stimulus
  • cerebellum development
  • cerebral cortex development
  • chromatin
  • chromatin binding
  • estrous cycle
  • hippocampus development
  • hypothalamus development
  • labyrinthine layer morphogenesis
  • lactation
  • mRNA transcription by RNA polymerase II
  • male gonad development
  • male mating behavior
  • nuclear estrogen receptor binding
  • nuclear receptor binding
  • nuclear receptor coactivator activity
  • nuclear retinoic acid receptor binding
  • nuclear retinoid X receptor binding
  • nucleus
  • positive regulation of DNA-templated transcription
  • positive regulation of apoptotic process
  • positive regulation of female receptivity
  • positive regulation of neuron differentiation
  • positive regulation of transcription by RNA polymerase II
  • positive regulation of transcription from RNA polymerase II promoter by galactose
  • protein dimerization activity
  • protein-containing complex
  • protein-containing complex binding
  • regulation of thyroid hormone mediated signaling pathway
  • response to estradiol
  • response to hormone
  • response to progesterone
  • response to retinoic acid
  • transcription coactivator activity
  • transcription regulator complex
  • GO:0000435
  • GO:0000785
  • GO:0000977
  • GO:0002155
  • GO:0003677
  • GO:0003682
  • GO:0003713
  • GO:0005634
  • GO:0005667
  • GO:0007595
  • GO:0008584
  • GO:0009725
  • GO:0016922
  • GO:0021549
  • GO:0021766
  • GO:0021854
  • GO:0021987
  • GO:0030331
  • GO:0030374
  • GO:0032355
  • GO:0032526
  • GO:0032570
  • GO:0032870
  • GO:0032991
  • GO:0042789
  • GO:0042974
  • GO:0043065
  • GO:0044849
  • GO:0044877
  • GO:0045666
  • GO:0045893
  • GO:0045925
  • GO:0045944
  • GO:0046965
  • GO:0046983
  • GO:0060179
  • GO:0060713
  • GO:0090575
  • GO:1904017
  • STRADA
9606
  • ATP binding
  • G1 to G0 transition
  • activation of protein kinase activity
  • cytoplasm
  • cytosol
  • intracellular protein-containing complex
  • kinase binding
  • nucleoplasm
  • nucleus
  • protein export from nucleus
  • protein kinase activator activity
  • protein serine/threonine kinase activator activity
  • serine/threonine protein kinase complex
  • GO:0005524
  • GO:0005634
  • GO:0005654
  • GO:0005737
  • GO:0005829
  • GO:0006611
  • GO:0019900
  • GO:0030295
  • GO:0032147
  • GO:0043539
  • GO:0070314
  • GO:0140535
  • GO:1902554
  • Tnfaip3
10116
  • B-1 B cell homeostasis
  • DNA binding
  • K63-linked deubiquitinase activity
  • K63-linked polyubiquitin modification-dependent protein binding
  • cell migration
  • cellular response to hydrogen peroxide
  • cellular response to lipopolysaccharide
  • cysteine-type deubiquitinase activity
  • cytoplasm
  • cytoskeleton organization
  • establishment of protein localization to vacuole
  • identical protein binding
  • kinase binding
  • negative regulation of B cell activation
  • negative regulation of CD40 signaling pathway
  • negative regulation of canonical NF-kappaB signal transduction
  • negative regulation of chronic inflammatory response
  • negative regulation of endothelial cell apoptotic process
  • negative regulation of extrinsic apoptotic signaling pathway
  • negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
  • negative regulation of inflammatory response
  • negative regulation of innate immune response
  • negative regulation of interleukin-1 beta production
  • negative regulation of interleukin-2 production
  • negative regulation of interleukin-6 production
  • negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway
  • negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway
  • negative regulation of protein ubiquitination
  • negative regulation of smooth muscle cell proliferation
  • negative regulation of toll-like receptor 3 signaling pathway
  • negative regulation of toll-like receptor 5 signaling pathway
  • negative regulation of tumor necrosis factor production
  • nucleus
  • positive regulation of Wnt signaling pathway
  • positive regulation of hepatocyte proliferation
  • positive regulation of protein catabolic process
  • protease binding
  • protein self-association
  • proteolysis
  • regulation of germinal center formation
  • response to molecule of bacterial origin
  • response to muramyl dipeptide
  • tolerance induction to lipopolysaccharide
  • ubiquitin binding
  • ubiquitin-protein transferase activity
  • zinc ion binding
  • GO:0001922
  • GO:0002020
  • GO:0002237
  • GO:0002634
  • GO:0002677
  • GO:0003677
  • GO:0004842
  • GO:0004843
  • GO:0005634
  • GO:0005737
  • GO:0006508
  • GO:0007010
  • GO:0008270
  • GO:0016477
  • GO:0019900
  • GO:0030177
  • GO:0031397
  • GO:0032495
  • GO:0032691
  • GO:0032703
  • GO:0032715
  • GO:0032720
  • GO:0034140
  • GO:0034148
  • GO:0042802
  • GO:0043124
  • GO:0043130
  • GO:0043621
  • GO:0045732
  • GO:0045824
  • GO:0048662
  • GO:0050728
  • GO:0050869
  • GO:0061578
  • GO:0070301
  • GO:0070429
  • GO:0070433
  • GO:0070530
  • GO:0071222
  • GO:0072573
  • GO:0072666
  • GO:1902042
  • GO:2000347
  • GO:2000349
  • GO:2000352
  • GO:2001237
  • TCDM_11175
1416333
Displaying entries 120191 - 120200 of 120208 in total

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01